Asymchem Laboratories (Tianjin) Co., Ltd. (FRA:7K90)

Market Cap	4.93B +44.1%
Revenue (ttm)	812.22M +14.9%
Net Income	137.91M +19.4%
EPS	0.38 +17.5%
Shares Out	n/a
PE Ratio	35.73
Forward PE	28.07
Dividend	0.13 (1.34%)
Ex-Dividend Date	Jun 25, 2025

Volume	n/a
Average Volume	16
Open	9.75
Previous Close	9.65
Day's Range	9.75 - 9.75
52-Week Range	5.25 - 12.30
Beta	n/a
RSI	50.67
Earnings Date	Mar 30, 2026

About FRA:7K90

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in ke...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 10,617
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7K90

Financial Performance

In 2025, FRA:7K90's revenue was 6.67 billion, an increase of 14.91% compared to the previous year's 5.80 billion. Earnings were 1.13 billion, an increase of 19.35%.

Financial numbers in CNY